Is there a role for urinary podocyte excretion assessment in lupus nephritis?

Detalhes bibliográficos
Autor(a) principal: Mansur, Juliana Busato [UNIFESP]
Data de Publicação: 2016
Outros Autores: Sabino, Amelia Rodrigues Pereira [UNIFESP], Nishida, Sonia Kiyomi [UNIFESP], Kirsztajn, Gianna Mastroianni [UNIFESP]
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNIFESP
Texto Completo: http://dx.doi.org/10.3109/0886022X.2016.1150099
https://repositorio.unifesp.br/handle/11600/56047
Resumo: Objective To establish the occurrence and intensity of podocyturia and its relation to grade of disease activity, as defined by clinical and laboratory criteria. Methods Prospective, cross-sectional study involving 50 patients with lupus nephritis and 29 controls, which had podocyturia levels determined from random urine samples using an immunofluorescence technique. Disease activity was graded by BILAG (renal criteria) and an additional system used in the service (S2). Results Fifty patients with lupus nephritis (WHO classes III, IV and V), with a median age of 37years, were evaluated. Of these, 86.5% were female, and 52% were BILAG A. Podocyturia quantification in the lupus nephritis and control groups differed significantly (p = 0.009). This score was higher in relation to classes III, IV and V. The correlation with C3 consumption was stronger (p = 0.011) than with C4. The highest levels were found in the most active groups (A and B of BILAG and S2). Lower podocyturia correlated with a lower dose of prednisone. There was no association with the intensity of proteinuria, hematuria or pyuria, serum creatinine levels, among others. Conclusions Podocyturia assessment, which was performed by immunofluorescence in this study, can be used as an indicator of disease activity with the advantage of being a urinary biomarker. The levels proved to be higher in patients with lupus nephritis than in the controls and were particularly higher in class IV.
id UFSP_b4cd4ce184a33e4f13448cf2348a13aa
oai_identifier_str oai:repositorio.unifesp.br/:11600/56047
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Is there a role for urinary podocyte excretion assessment in lupus nephritis?Glomerulonephritissystemic lupus erythematosuslupus nephritispodocyturiapodocytesproteinuriaObjective To establish the occurrence and intensity of podocyturia and its relation to grade of disease activity, as defined by clinical and laboratory criteria. Methods Prospective, cross-sectional study involving 50 patients with lupus nephritis and 29 controls, which had podocyturia levels determined from random urine samples using an immunofluorescence technique. Disease activity was graded by BILAG (renal criteria) and an additional system used in the service (S2). Results Fifty patients with lupus nephritis (WHO classes III, IV and V), with a median age of 37years, were evaluated. Of these, 86.5% were female, and 52% were BILAG A. Podocyturia quantification in the lupus nephritis and control groups differed significantly (p = 0.009). This score was higher in relation to classes III, IV and V. The correlation with C3 consumption was stronger (p = 0.011) than with C4. The highest levels were found in the most active groups (A and B of BILAG and S2). Lower podocyturia correlated with a lower dose of prednisone. There was no association with the intensity of proteinuria, hematuria or pyuria, serum creatinine levels, among others. Conclusions Podocyturia assessment, which was performed by immunofluorescence in this study, can be used as an indicator of disease activity with the advantage of being a urinary biomarker. The levels proved to be higher in patients with lupus nephritis than in the controls and were particularly higher in class IV.Univ Fed Sao Paulo, UNIFESP, Div Nephrol, Napoleao de Barros St 715, BR-04024002 Sao Paulo, BrazilUniv Fed Sao Paulo, UNIFESP, Div Nephrol, Napoleao de Barros St 715, BR-04024002 Sao Paulo, BrazilWeb of ScienceBrazilian Council for Scientific and Technological Development (CNPq)Taylor & Francis Ltd2020-07-22T13:23:07Z2020-07-22T13:23:07Z2016info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion643-647http://dx.doi.org/10.3109/0886022X.2016.1150099Renal Failure. Abingdon, v. 38, n. 4, p. 643-647, 2016.10.3109/0886022X.2016.11500990886-022Xhttps://repositorio.unifesp.br/handle/11600/56047WOS:000372164000022engRenal FailureAbingdoninfo:eu-repo/semantics/openAccessMansur, Juliana Busato [UNIFESP]Sabino, Amelia Rodrigues Pereira [UNIFESP]Nishida, Sonia Kiyomi [UNIFESP]Kirsztajn, Gianna Mastroianni [UNIFESP]reponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2021-10-04T21:26:15Zoai:repositorio.unifesp.br/:11600/56047Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652021-10-04T21:26:15Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.none.fl_str_mv Is there a role for urinary podocyte excretion assessment in lupus nephritis?
title Is there a role for urinary podocyte excretion assessment in lupus nephritis?
spellingShingle Is there a role for urinary podocyte excretion assessment in lupus nephritis?
Mansur, Juliana Busato [UNIFESP]
Glomerulonephritis
systemic lupus erythematosus
lupus nephritis
podocyturia
podocytes
proteinuria
title_short Is there a role for urinary podocyte excretion assessment in lupus nephritis?
title_full Is there a role for urinary podocyte excretion assessment in lupus nephritis?
title_fullStr Is there a role for urinary podocyte excretion assessment in lupus nephritis?
title_full_unstemmed Is there a role for urinary podocyte excretion assessment in lupus nephritis?
title_sort Is there a role for urinary podocyte excretion assessment in lupus nephritis?
author Mansur, Juliana Busato [UNIFESP]
author_facet Mansur, Juliana Busato [UNIFESP]
Sabino, Amelia Rodrigues Pereira [UNIFESP]
Nishida, Sonia Kiyomi [UNIFESP]
Kirsztajn, Gianna Mastroianni [UNIFESP]
author_role author
author2 Sabino, Amelia Rodrigues Pereira [UNIFESP]
Nishida, Sonia Kiyomi [UNIFESP]
Kirsztajn, Gianna Mastroianni [UNIFESP]
author2_role author
author
author
dc.contributor.author.fl_str_mv Mansur, Juliana Busato [UNIFESP]
Sabino, Amelia Rodrigues Pereira [UNIFESP]
Nishida, Sonia Kiyomi [UNIFESP]
Kirsztajn, Gianna Mastroianni [UNIFESP]
dc.subject.por.fl_str_mv Glomerulonephritis
systemic lupus erythematosus
lupus nephritis
podocyturia
podocytes
proteinuria
topic Glomerulonephritis
systemic lupus erythematosus
lupus nephritis
podocyturia
podocytes
proteinuria
description Objective To establish the occurrence and intensity of podocyturia and its relation to grade of disease activity, as defined by clinical and laboratory criteria. Methods Prospective, cross-sectional study involving 50 patients with lupus nephritis and 29 controls, which had podocyturia levels determined from random urine samples using an immunofluorescence technique. Disease activity was graded by BILAG (renal criteria) and an additional system used in the service (S2). Results Fifty patients with lupus nephritis (WHO classes III, IV and V), with a median age of 37years, were evaluated. Of these, 86.5% were female, and 52% were BILAG A. Podocyturia quantification in the lupus nephritis and control groups differed significantly (p = 0.009). This score was higher in relation to classes III, IV and V. The correlation with C3 consumption was stronger (p = 0.011) than with C4. The highest levels were found in the most active groups (A and B of BILAG and S2). Lower podocyturia correlated with a lower dose of prednisone. There was no association with the intensity of proteinuria, hematuria or pyuria, serum creatinine levels, among others. Conclusions Podocyturia assessment, which was performed by immunofluorescence in this study, can be used as an indicator of disease activity with the advantage of being a urinary biomarker. The levels proved to be higher in patients with lupus nephritis than in the controls and were particularly higher in class IV.
publishDate 2016
dc.date.none.fl_str_mv 2016
2020-07-22T13:23:07Z
2020-07-22T13:23:07Z
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.3109/0886022X.2016.1150099
Renal Failure. Abingdon, v. 38, n. 4, p. 643-647, 2016.
10.3109/0886022X.2016.1150099
0886-022X
https://repositorio.unifesp.br/handle/11600/56047
WOS:000372164000022
url http://dx.doi.org/10.3109/0886022X.2016.1150099
https://repositorio.unifesp.br/handle/11600/56047
identifier_str_mv Renal Failure. Abingdon, v. 38, n. 4, p. 643-647, 2016.
10.3109/0886022X.2016.1150099
0886-022X
WOS:000372164000022
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Renal Failure
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 643-647
dc.coverage.none.fl_str_mv Abingdon
dc.publisher.none.fl_str_mv Taylor & Francis Ltd
publisher.none.fl_str_mv Taylor & Francis Ltd
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv biblioteca.csp@unifesp.br
_version_ 1814268413670850560